ArticleMedicine2026
The correlation between height and assay parameters in children with short stature.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
It is known that growth hormone plays a major role in children's height. This research was conducted to explore the connection between children's height and other parameters for potential diagnostic markers in cases of short stature. Information was gathered from children diagnosed with short stature from our hospital, including fundamental data and assay findings, and was evaluated for the correlation between height and assay findings. The correlation between height and assay findings was evaluated using the Pearson correlation coefficient test. A total of 2396 children were included, with 61.4% being boys, who exhibited a higher prevalence across most age groups. The findings revealed moderate positive correlations between height and iron, hemoglobin, as well as a weak correlation with zinc (iron, r = 0.48, hemoglobin, r = 0.52, zinc, r = 0.29, P < .0001, respectively). Additionally, a moderate negative correlation was observed between height and 25-hydroxyvitamin D (r = -0.37, P < .0001). Height showed highly positive correlations with insulin-like growth factor-1 (r = 0.67, P < .0001) and insulin-like growth factor binding protein 3 levels (r = 0.66, P < .0001), and moderate positive associations with sex hormones (follicle-stimulating hormone: r = 0.43, luteinizing hormone: r = 0.42; testosterone: r = 0.5, P < .0001, respectively). Furthermore, a moderate positive correlation was found between height and glucose (r = 0.41, P < .0001), while no significant correlation was observed between height and lipid metabolism parameters. In summary, short stature is a prevalent issue in our country. The research emphasized the correlation of height with insulin-like growth factor-1, insulin-like growth factor binding protein 3, and other parameters, and a negligible correlation with lipid metabolism parameters. These findings can serve as valuable parameters for parents to seek medical attention for children exhibiting abnormal results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.